Recent filings by Aurobindo Pharma Limited

Published Title Summary
2026-01-01 18:12:14 Acquisition-XBRL AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition
2026-01-01 18:02:52 Acquisition Aurobindo Pharma Limited has informed the Exchange about acquisition of...
Aurobindo Pharma Limited has informed the Exchange about acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Limited as a going concern, including without limitation inventory, intellectual property, employees, contracts etc. on a slump sale basis is being acquired by Auro Pharma Limited, a wholly owned subsidiary of the Company.
2025-12-30 11:23:56 Acquisition Aurobindo Pharma Limited has informed the Exchange about update on...
Aurobindo Pharma Limited has informed the Exchange about update on acquisition of 26% stake in Swarnaakshu Solar Power Private Limited
2025-10-01 11:58:59 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-09-26 17:29:15 Acquisition Aurobindo Pharma Limited has updated the Exchange about transfer of...
Aurobindo Pharma Limited has updated the Exchange about transfer of shares among subsidiary companies
2025-09-26 15:51:00 Acquisition Aurobindo Pharma Limited has updated on acquisition of 26% stake...
Aurobindo Pharma Limited has updated on acquisition of 26% stake in Swarnaakshu Solar Power Private Limited
2025-08-29 15:56:12 Acquisition Aurobindo Pharma Limited has informed the Exchange about ppdate on...
Aurobindo Pharma Limited has informed the Exchange about ppdate on entering into a binding agreement for transfer of shares of CuraTeQ Biologics s.r.o., by Helix Healthcare B.V., to Curateq Biologics B.V., wholly owned subsidiaries of the Company
2025-08-04 19:34:13 Record Date Aurobindo Pharma Limited has informed the Exchange that Record date...
Aurobindo Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 08-Aug-2025.
2025-07-31 18:06:01 Acquisition-XBRL AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition
2025-07-30 19:44:14 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-07-30 17:47:00 Acquisition-XBRL AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition
2025-07-30 17:45:30 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-03-28 11:20:51 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-02-28 17:55:09 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-02-07 14:47:36 Acquisition-XBRL AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition
2025-02-07 14:45:47 Acquisition-XBRL AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition
2025-02-06 20:25:54 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-02-06 20:03:05 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2025-01-17 12:05:32 Board Meeting Intimation AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting...
AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 06-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2024-09-18 17:28:51 Acquisition-XBRL AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition
2024-09-18 15:27:06 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition
2024-08-26 13:34:44 Buyback Aurobindo Pharma Limited has informed the Exchange about Buyback...
Aurobindo Pharma Limited has informed the Exchange about Buyback
2024-07-31 10:15:15 Board Meeting Intimation AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting...
AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
2024-05-02 14:32:31 Acquisition Aurobindo Pharma Limited has informed the Exchange about Acquisition...
Aurobindo Pharma Limited has informed the Exchange about Acquisition